On Friday, Altimmune Inc (NASDAQ: ALT) opened lower -5.14% from the last session, before settling in for the closing price of $7.00. Price fluctuations for ALT have ranged from $5.28 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 154.97%. Company’s average yearly earnings per share was noted 18.37% at the time writing. With a float of $70.47 million, this company’s outstanding shares have now reached $71.12 million.
Considering the fact that the conglomerate employs 59 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -3857.69%, operating margin of -191365.38%, and the pretax margin is -199076.92%.
Altimmune Inc (ALT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 0.84%, while institutional ownership is 55.99%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.35% during the next five years compared to 35.74% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 16.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9445.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Compared to the last year’s volume of 2.25 million, its volume of 2.03 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 31.47%. Additionally, its Average True Range was 0.44.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 14.72%, which indicates a significant decrease from 36.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.52% in the past 14 days, which was lower than the 79.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.82, while its 200-day Moving Average is $7.15. Nevertheless, the first resistance level for the watch stands at $6.91 in the near term. At $7.19, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.34. If the price goes on to break the first support level at $6.49, it is likely to go to the next support level at $6.34. Should the price break the second support level, the third support level stands at $6.06.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 71,125K shares outstanding in the company with a market cap of 472.27 million. Presently, the company’s annual sales total 430 K according to its annual income of -88,450 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -22,850 K.
